Complexity of desire for hastened death in terminally ill cancer patients: A cluster analysis
Complexity of desire for hastened death in terminally ill cancer patients: A cluster analysis
复制标题
癌症晚期患者加速死亡愿望的复杂性:聚类分析
DOI:
10.1017/s1478951521000080
复制
发表时间:
2021
影响因子:
2.2
通讯作者:
on behalf of the EASED Investigators
中科院分区:
文献类型:
--
作者:
Hatano Yutaka;Morita Tatsuya;Mori Masanori;Maeda Isseki;Oyamada Shunsuke;Naito Akemi Shirado;Oya Kiyofumi;Sakashita Akihiro;Ito Satoko;Hiratsuka Yusuke;Tsuneto Satoru;on behalf of the EASED Investigators
ObjectivesThe present study aims were (1) to identify the proportion of terminally ill cancer patients with desire for hastened death (DHD) receiving specialized palliative care, (2) to identify the reasons for DHD, and (3) to classify patients with DHD into some interpretable subgroups.MethodsAdvanced cancer patients admitted to 23 inpatients hospices/palliative care units in 2017 were enrolled. Data were prospectively obtained by the primarily responsible physicians. The presence/absence of DHD and reasons for DHD were recorded. A cluster analysis was performed to identify patterns of subgroups in patients with DHD.ResultsData from 971 patients, whose Richmond Agitation–Sedation Scale score at admission was zero and who died in palliative care units, were analyzed. The average age was 72 years, common primary cancer sites were the gastrointestinal tract (31%) and the liver/biliary ducts/pancreas (19%). A total of 174 patients (18%: 95% confidence interval, 16–20) expressed DHD. Common reasons for DHD were dependency (45%), burden to others (28%), meaninglessness (24%), and inability to engage in pleasant activities (24%). We identified five clusters of patients with DHD: cluster 1 (35%, 61/173): “physical distress,” cluster 2 (21%, 37/173): “dependent and burdensome,” cluster 3 (19%, 33/173): “hopelessness,” cluster 4 (17%, 30/173): “profound fatigue,” and cluster 5 (7%, 12/173): “extensive existential suffering.”ConclusionsA considerable number of patients expressed DHD and could be categorized into five subgroups. These findings may contribute to the development of therapeutic strategies.
登录
查看更多内容
影响因子:
45.3
作者:
M. Suarez‐Almazor;C. Newman;J. Hanson;E. Bruera
通讯作者:
E. Bruera
DOI:
10.1136/bmj.a1682
发表时间:
2008-10-07
期刊:
BMJ (Clinical research ed.)
影响因子:
--
作者:
Ganzini L;Goy ER;Dobscha SK
通讯作者:
Dobscha SK
影响因子:
3.6
作者:
Christian Villavicencio;C. Monforte;Joaquín Tomás;Markus A. Maier;J. Porta;A. Balaguer
通讯作者:
A. Balaguer
影响因子:
4.7
作者:
Yao, Chien-An;Hu, Wen-Yu;Chiu, Tai-Yuan
通讯作者:
Chiu, Tai-Yuan
影响因子:
3.4
作者:
Chochinov, HM;Wilson, KG;Lander, S
通讯作者:
Lander, S